FDMT vs PYPL · rev $37.0K vs P/E 7.9, rev $33.17B
4D Molecular Therapeutics Inc (FDMT) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
FDMT currently screens at market cap $518.1M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the FDMT and PYPL stock pages for the full models.
Not investment advice.